Population-Based Study | sciencenewsnet.in

Breaking News

How chain IVF clinics improve infertility treatment

CSUF’s Visual Arts Complex Redesigned for the Future of Art Education

Research shows how corporate social responsibility messaging can backfire

UNPAID CAREGIVING IS UNDERVALUED BY SOCIETY

Student debt: An individual and collective burden at English-language universities

Expert Available: Vance Refuses to Acknowledge 2020 Election Results in Interview

Corcoran School of Arts & Design at GW to Host Music Festival Featuring Local Talent

Morgane Schambourg: A veterinarian dedicated to advancing equine medicine

Democrats and Republicans agree on one thing: Censoring hate speech

WashU researchers use genetics to find psychopathology risks

18 Oct, 2024

New Cedars-Sinai Study Investigates Shifting Trends in GLP-1RA Prescription

July 23, 2024 sarah JonasResearch Results

Investigators at Cedars-Sinai and other institutions conducted a nationwide, population-based study to identify trends in the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs)—prescription medications sold under popular drug names like Ozempic and Wegovy—in the United States.